This suggested significant biological differences in the behavior of the fimbria in high-grade and low-grade ovarian serous cancers (OSCs) and we presumed that the susceptibility to FSH of fimbria of high- and low-grade OSCs are different. This evidence concerns the gene BRD2 and ovarian serous adenocarcinoma.